Evidence map›Paper›PMID 25675510›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Neuroinflammation triggered by β-glucan/dectin-1 signaling enables CNS axon regeneration.

Katherine T Baldwin, Kevin S Carbajal, Benjamin M Segal, Roman J Giger

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Synthetic Ligands of Myeloid C-Type Lectin Receptors.Chembiochem : a European journal of chemical biology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Microglial dectin-1/Frontiers in immunology · 2026
    Article
  8. Review
  9. Microglial CLEC7A restrains amyloid beta plaque pathology in a mouse model of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  10. Review
  11. The neuroimmune interface in retinal regeneration.Progress in retinal and eye research · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Katherine T BaldwinDepartment of Cell and Developmental Biology, Cellular and Molecular Biology Graduate Program.
Kevin S CarbajalNeuroscience Graduate Program, and Holtom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109.
Benjamin M SegalNeuroscience Graduate Program, and Holtom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109 bmsegal@umich.edu rgiger@umich.edu.
Roman J GigerDepartment of Cell and Developmental Biology, Cellular and Molecular Biology Graduate Program, Neuroscience Graduate Program, and Holtom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109 bmsegal@umich.edu rgiger@umich.edu.
University of Michigan–Ann Arbor · US

Funding

CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
TRAINING IN CLINICAL AND BASIC NEUROSCIENCET32NS007222 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Henry L Paulson · 1985 to 2026
$8.0M
Neuronal regulation of myelinationR01NS081281 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIGER, ROMAN JENO · 2012 to 2016
$1.7M
The regulation of myeloid cell development and mobilization during autoimmune demR01NS057670 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEGAL, BENJAMIN M · 2010 to 2014
$1.3M
Nogo receptor function at the synapseF31NS081852 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BALDWIN, KATHERINE THERESE · 2013 to 2014
$66k
Preclinical studies of a MADCAM-Fc fusion protein in multiple sclerosisI01RX000416 · VA · VETERANS HEALTH ADMINISTRATION · PI SEGAL, BENJAMIN M · 2012 to 2015
–
Nogo Receptors as Therapeutic Targets in a Model of Multiple SclerosisI01BX001387 · VA · VETERANS HEALTH ADMINISTRATION · PI SEGAL, BENJAMIN M · 2013 to 2016
–
BLRD VA I01 BX001387NIAID NIH HHS T32 AI007413NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32GM007315NINDS NIH HHS 3T32NS007222-31S1NINDS NIH HHS F31 NS081852NINDS NIH HHS F31NS081852NINDS NIH HHS R01 NS057670NINDS NIH HHS R01 NS081281NINDS NIH HHS T32 NS007222RRD VA I01 RX000416
6 · The paper itself

Abstract

Innate immunity can facilitate nervous system regeneration, yet the underlying cellular and molecular mechanisms are not well understood. Here we show that intraocular injection of lipopolysaccharide (LPS), a bacterial cell wall component, or the fungal cell wall extract zymosan both lead to rapid and comparable intravitreal accumulation of blood-derived myeloid cells. However, when combined with retro-orbital optic nerve crush injury, lengthy growth of severed retinal ganglion cell (RGC) axons occurs only in zymosan-injected mice, and not in LPS-injected mice. In mice deficient for the pattern recognition receptor dectin-1 but not Toll-like receptor-2 (TLR2), zymosan-mediated RGC regeneration is greatly reduced. The combined loss of dectin-1 and TLR2 completely blocks the proregenerative effects of zymosan. In the retina, dectin-1 is expressed by microglia and dendritic cells, but not by RGCs. Dectin-1 is also present on blood-derived myeloid cells that accumulate in the vitreous. Intraocular injection of the dectin-1 ligand curdlan [a particulate form of β(1, 3)-glucan] promotes optic nerve regeneration comparable to zymosan in WT mice, but not in dectin-1(-/-) mice. Particulate β(1, 3)-glucan leads to increased Erk1/2 MAP-kinase signaling and cAMP response element-binding protein (CREB) activation in myeloid cells in vivo. Loss of the dectin-1 downstream effector caspase recruitment domain 9 (CARD9) blocks CREB activation and attenuates the axon-regenerative effects of β(1, 3)-glucan. Studies with dectin-1(-/-)/WT reciprocal bone marrow chimeric mice revealed a requirement for dectin-1 in both retina-resident immune cells and bone marrow-derived cells for β(1, 3)-glucan-elicited optic nerve regeneration. Collectively, these studies identify a molecular framework of how innate immunity enables repair of injured central nervous system neurons.

Indexed as

AnimalsAxonsbeta-GlucansCARD Signaling Adaptor ProteinsCentral Nervous SystemCyclic AMP Response Element-Binding ProteinDectin-1InflammationLectins, C-TypeLipopolysaccharidesMice, Inbred C57BLMicrogliaMyeloid CellsMyeloid Differentiation Factor 88Nerve RegenerationPhagocytosisbeta-GlucansCard9 protein, mouseCARD Signaling Adaptor ProteinscurdlanCyclic AMP Response Element-Binding ProteinDectin-1Lectins, C-TypeLipopolysaccharidesMyeloid Differentiation Factor 88Toll-Like Receptor 2Zymosandectin-1mouseneuroinflammationoptic nerveregeneration

Identifiers

PMID25675510
PMCPMC4345569
OpenAlexW1984417027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.